Th17 Cell enhances CD8 T-cell cytotoxicity via IL-21 production in emphysema mice

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Duan, Min Chao ^a   Huang, Ying ^a   Zhong, Xiao Ning ^a   Tang, Hai Juan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 21; PERFORIN; GRANZYME; INTERLEUKIN DERIVATIVE; PERFORIN, MOUSE; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CYTOKINE PRODUCTION; CYTOTOXICITY; EMPHYSEMA; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH17 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EMPHYSEMA; GRANZYMES; INTERLEUKIN-17; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; TH17 CELLS;

MLCS; MLOWN;

EID: 84872798648     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/898053     Document Type: Article

References (46)

1. Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2011, http://www.goldcopd.com/
2. National Institute for Health and Clinical Excellence, Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. National Clinical Guideline Centre, London, UK, 2010, http://guidance.nice.org.uk/CG101/Guidance/pdf/English
3. Niewoehner D. E., Outpatient management of severe COPD. The New England Journal of Medicine 2010 362 15 1407 1416 2-s2.0-77950995260 10.1056/NEJMcp0912556
4. Cosio M. G., Majo J., Cosio M. G., Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002 121 5 2-s2.0-0036257614
5. Agustí A., MacNee W., Donaldson K., Cosio M., Hypothesis: does COPD have an autoimmune component? Thorax 2003 58 10 832 834 2-s2.0-0141887302 10.1136/thorax.58.10.832 (Pubitemid 37239227)
6. Lee S. H., Goswami S., Grudo A., Song L. Z., Bandi V., Goodnight-White S., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H. O., Cogswell S., Storness-Bliss C., Corry D. B., Kheradmand F., Antielastin autoimmunity in tobacco smoking-induced emphysema. Nature Medicine 2007 13 5 567 569 2-s2.0-34249652351 10.1038/nm1583 (Pubitemid 46828488)
7. Rouvier E., Luciani M. F., Mattei M. G., Denizot F., Golstein P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene. Journal of Immunology 1993 150 12 5445 5456 2-s2.0-0027215897 (Pubitemid 23180658)
8. Kawaguchi M., Onuchic L. F., Li X. D., Essayan D. M., Schroeder J., Xiao H. Q., Liu M. C., Krishnaswamy G., Germino G., Huang S. K., Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. Journal of Immunology 2001 167 8 4430 4435 2-s2.0-0035888025 (Pubitemid 32954320)
9. Hizawa N., Kawaguchi M., Huang S. K., Nishimura M., Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clinical and Experimental Allergy 2006 36 9 1109 1114 2-s2.0-33748429852 10.1111/j.1365-2222. 2006.02550.x (Pubitemid 44342924)
10. Di Stefano A., Caramori G., Gnemmi I., Contoli M., Vicari C., Capelli A., Magno F., D'Anna S. E., Zanini A., Brun P., Casolari P., Chung K. F., Barnes P. J., Papi A., Adcock I., Balbi B., T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clinical and Experimental Immunology 2009 157 2 316 324 2-s2.0-67650653218 10.1111/j.1365-2249.2009.03965.x
11. Pelletier M., Maggi L., Micheletti A., Lazzeri E., Tamassia N., Costantini C., Cosmi L., Lunardi C., Annunziato F., Romagnani S., Cassatella M. A., Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010 115 2 335 343 2-s2.0-75649148842 10.1182/blood-2009-04-216085
12. Chen Y., Thai P., Zhao Y. H., Ho Y. S., DeSouza M. M., Wu R., Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. Journal of Biological Chemistry 2003 278 19 17036 17043 2-s2.0-0037592950 10.1074/jbc.M210429200 (Pubitemid 36799579)
13. Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y. H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005 6 11 1133 1141 2-s2.0-27544465354 10.1038/ni1261 (Pubitemid 41541791)
14. Nistala K., Moncrieffe H., Newton K. R., Varsani H., Hunter P., Wedderburn L. R., Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis and Rheumatism 2008 58 3 875 887 2-s2.0-40549138745 10.1002/art.23291 (Pubitemid 351364887)
15. Tzartos J. S., Friese M. A., Craner M. J., Palace J., Newcombe J., Esiri M. M., Fugger L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. American Journal of Pathology 2008 172 1 146 155 2-s2.0-38749143286 10.2353/ajpath.2008.070690 (Pubitemid 351186376)
16. Chang Y., Nadigel J., Boulais N., Bourbeau J., Maltais F., Eidelman D. H., Hamid Q., CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respiratory Research 2011 12 43 50 10.1186/1465-9921-12-43
17. Shan M., Cheng H. F., Song L. Z., Roberts L., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H. O., Storness-Bliss C., Ramchandani M., Lee S. H., Corry D. B., Kheradmand F., Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Science Translational Medicine 2009 1 4 ra10 2-s2.0-77954664861 10.1126/scitranlsmed.3000154
18. Monteleone G., Pallone F., Macdonald T. T., Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends in Pharmacological Sciences 2009 30 8 441 447 2-s2.0-67849120058 10.1016/j.tips.2009.05.006
19. Nurieva R., Yang X. O., Martinez G., Zhang Y., Panopoulos A. D., Ma L., Schluns K., Tian Q., Watowich S. S., Jetten A. M., Dong C., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007 448 7152 480 483 2-s2.0-34547204946 10.1038/nature05969 (Pubitemid 47123514)
20. Mehta D. S., Wurster A. L., Grusby M. J., Biology of IL-21 and the IL-21 receptor. Immunological Reviews 2004 202 84 95 2-s2.0-9644278059 10.1111/j.0105-2896.2004.00201.x (Pubitemid 39576906)
21. + T cell expansion and function. Journal of Experimental Medicine 2005 201 1 139 148 2-s2.0-19944434230 10.1084/jem.20041057 (Pubitemid 40130091)
22. D'hulst A. I., Vermaelen K. Y., Brusselle G. G., Joos G. F., Pauwels R. A., Time course of cigarette smoke-induced pulmonary inflammation in mice. European Respiratory Journal 2005 26 2 204 213 2-s2.0-23144466310 10.1183/09031936.05.00095204 (Pubitemid 41079063)
23. Macdonald G., Kondor N., Yousefi V., Green A., Wong F., Aquino-Parsons C., Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiotherapy and Oncology 2004 73 3 367 371 2-s2.0-10044248516 10.1016/j.radonc.2004.09.002 (Pubitemid 39601087)
24. Saetta M., Shiner R. J., Angus G. E., Kim W. D., Wang N. S., King M., Ghezzo H., Cosio M. G., Destructive index: a mesurement of lung parenchymal destruction in smokers. American Review of Respiratory Disease 1985 131 5 764 769 2-s2.0-0021893496 (Pubitemid 15066865)
25. Thurlbeck W. M., Measurement of pulmonary emphysema. American Review of Respiratory Disease 1967 95 5 752 764 2-s2.0-0014089071
26. Vermaelen K. Y., Carro-Muino I., Lambrecht B. N., Pauwels R. A., Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. Journal of Experimental Medicine 2001 193 1 51 60 2-s2.0-0035177431 10.1084/jem.193.1.51 (Pubitemid 32060697)
27. Voßhenrich C. A. J., Di Santo J. P., Cytokines: IL-21 joins the γ c-dependent network? Current Biology 2001 11 5 R175 R177 2-s2.0-0035814926 10.1016/S0960-9822(01)00087-2 (Pubitemid 32200728)
28. Li Y., Bleakley M., Yee C., IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. Journal of Immunology 2005 175 4 2261 2269 2-s2.0-23444445913 (Pubitemid 41113833)
29. Barnes P. J., Cosio M. G., Characterization of T lymphocytes in chronic obstructive pulmonary disease. PLoS Medicine 2004 1 e20 2-s2.0-15744364004 10.1371/journal.pmed.0010020 (Pubitemid 40412693)
30. Reiner S. L., Development in motion: helper T cells at work. Cell 2007 129 1 33 36 2-s2.0-33947720523 10.1016/j.cell.2007.03.019 (Pubitemid 46507593)
31. Sakaguchi S., Sakaguchi N., Regulatory T cells in immunologic self-tolerance and autoimmune disease. International Reviews of Immunology 2005 24 3-4 211 226 2-s2.0-22244462396 10.1080/08830180590934976 (Pubitemid 40991002)
32. Steinman L., A brief history of TH17, the first major revision in the T H1/TH2 hypothesis of T cell-mediated tissue damage. Nature Medicine 2007 13 2 139 145 2-s2.0-33846966636 10.1038/nm1551
33. + regulatory T cells in inflammation and emphysema after smoking cessation in rats. Chinese Journal of Tuberculosis and Respiratory Diseases 2010 33 9 688 692
34. + T helper lymphocytes on cigarette smoke-induced lung inflammation and emphysema in mice. Chinese Journal of Tuberculosis and Respiratory Diseases 2011 34 4 259 264
35. + Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunology Letters 2008 121 1 13 21 2-s2.0-54049158837 10.1016/j.imlet.2008.07.011
36. Korn T., Bettelli E., Oukka M., Kuchroo V. K., IL-17 and Th17 cells. Annual Review of Immunology 2009 27 485 517 2-s2.0-61949463911 10.1146/annurev.immunol.021908.132710
37. Prause O., Bozinovski S., Anderson G. P., Lindén A., Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 2004 59 4 313 317 2-s2.0-1942501856 10.1136/thx.2003.008854 (Pubitemid 38496749)
38. Alcorn J. F., Crowe C. R., Kolls J. K., TH17 cells in asthma and COPD. Annual Review of Physiology 2009 72 495 516 2-s2.0-77951885204 10.1146/annurev-physiol-021909-135926
39. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T. B., Oukka M., Kuchroo V. K., IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells. Nature 2007 448 7152 484 487 2-s2.0-34547232503 10.1038/nature05970 (Pubitemid 47123515)
40. Nurieva R., Yang X. O., Martinez G., Zhang Y., Panopoulos A. D., Ma L., Schluns K., Tian Q., Watowich S. S., Jetten A. M., Dong C., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007 448 7152 480 483 2-s2.0-34547204946 10.1038/nature05969 (Pubitemid 47123514)
41. Monteleone G., Pallone F., MacDonald T. T., Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends in Immunology 2008 29 6 290 294 2-s2.0-44549084734 10.1016/j.it.2008.02. 008
42. Leonard W. J., Spolski R., Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nature Reviews Immunology 2005 5 9 688 698 2-s2.0-25444434157 10.1038/nri1688 (Pubitemid 43086171)
43. + T lymphocytes with FEV1. American Journal of Respiratory and Critical Care Medicine 1997 155 3 852 857 2-s2.0-0030900606 (Pubitemid 27133393)
44. + lymphocytes in patients with COPD. Chest 2004 125 1 71 76 2-s2.0-1642534601 10.1378/chest.125.1.71 (Pubitemid 38114566)
45. + T cells after acute infection. Nature Immunology 2004 5 9 927 933 2-s2.0-4644271443 10.1038/ni1105 (Pubitemid 39276237)
46. Trapani J. A., Smyth M. J., Functional significance of the perforin/granzyme cell death pathway. Nature Reviews Immunology 2002 2 10 735 747 2-s2.0-0036779576 10.1038/nri911 (Pubitemid 37328714)